- Dr. Parunyou Julayanont, MD, served as an assistant professor at the Division of Alzheimer's and Memory Disorders within the Department of Neurology at Barrow Neurological Institute and the University of Arizona in Phoenix, Arizona, USA from 2022 to 2024. During this time, he was the principal investigator and co-investigator in numerous clinical trials related to Alzheimer's and other neurodegenerative diseases.| - Prior to this role, he was an assistant professor at the Department of Neurology, Texas Tech University Health Sciences Center School of Medicine in Lubbock, Texas, USA from 2019 to 2022, where he served as the Endowed Chair of Alzheimer's Disease and director of the Dementia and Cognitive Neurology Clinic.| - Dr. Julayanont's areas of interest include multidisciplinary care for patients with Alzheimer's disease, Dementia with Lewy bodies, Parkinson's disease with dementia, other neurodegenerative diseases, and the interface between behavioral neurology and movement disorders.

1. Julayanont, P., and Nasreddine, Z.S. "The Montreal Cognitive Assessment (MoCA): Concept and Clinical review". In Larner A.J., Cognitive Screening Instruments: A Practical Approach Second Edition (pp. 139-196). London, England: Springer.
2. Julayanont, P., Tangwongchai, S.,Hemrungrojn, S., Tunvirachaisakul, C., Phanthumchinda, K., Hongsawat, J., Suwichanarakul, P., Thanasirorat, S., and Nasreddine, Z. The Montreal Cognitive Assessment-Basic (MoCA-Basic): A Screening Tool for Mild Cognitive Impairment for Illiterate and Low-Educated Elders. J Am Geriatr Soc. 2015 Dec;63(12):2550-2554.
3. All publications link: https://pubmed.ncbi.nlm.nih.gov/?term=Julayanont+P&sort=date